Metalloprotein-based MRI probes

FEBS Letters

Volumn 587, Issue 8, 2013, Pages 1021-1029

  Matsumoto, Yuri ^a   Jasanoff, Alan ^a,b  

^a USA   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Contrast agent; Magnetic resonance imaging; Metalloprotein; Molecular imaging; Protein engineering; Sensor

Indexed keywords

CONTRAST MEDIUM; GADOLINIUM; IRON OXIDE; METALLOPROTEIN;

BIOTECHNOLOGY; BOLD SIGNAL; CONCENTRATION (PARAMETERS); DRUG TARGETING; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; MOLECULAR IMAGING; MOLECULAR PROBE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN ENGINEERING; PROTEIN FUNCTION; REVIEW;

CONTRAST MEDIA; FERUMOXYTOL; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; METALLOPROTEINS; MODELS, CHEMICAL; MODELS, MOLECULAR; MUTATION; PROTEIN ENGINEERING;

EID: 84876054558     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2013.01.044     Document Type: Review

References (127)

1. K.J. Waldron, J.C. Rutherford, D. Ford, and N.J. Robinson Metalloproteins and metal sensing Nature 460 2009 823 830
2. Y. Lu, N. Yeung, N. Sieracki, and N.M. Marshall Design of functional metalloproteins Nature 460 2009 855 862
3. D. Voet, and J.G. Voet Biochemistry 2004 J. Wiley & Sons New York
4. E. Hochuli, W. Bannwarth, H. Döbeli, R. Gentz, and D. Stüber Genetic approach to facilitate purification of recombinant proteins with a novel metal chelate adsorbent Nat. Biotechnol. 6 1988 1321 1325
5. T.C. Hazen Cometabolic Bioremediation K.N. Timmis, Handbook of Hydrocarbon and Lipid Microbiology 2010 Springer Berlin Heidelberg Berlin, Heidelberg 2505 2514
6. B.G. Fox, J.G. Borneman, L.P. Wackett, and J.D. Lipscomb Haloalkene oxidation by the soluble methane monooxygenase from Methylosinus trichosporium OB3b: mechanistic and environmental implications Biochemistry 29 1990 6419 6427
7. A. Alessandrini, M. Salerno, S. Frabboni, and P. Facci Single-metalloprotein wet biotransistor Appl. Phys. Lett. 86 2005 133902 133904
8. A.K. Yagati, T. Lee, J. Min, and J.W. Choi A robust nanoscale biomemory device composed of recombinant azurin on hexagonally packed Au-nano array Biosens. Bioelectron. 40 2013 283 290
9. H.B. Kram Noninvasive tissue oxygen monitoring in surgical and critical care medicine Surg. Clin. North Am. 65 1985 1005 1024
10. E.S. Boyden, F. Zhang, E. Bamberg, G. Nagel, and K. Deisseroth Millisecond-timescale, genetically targeted optical control of neural activity Nat. Neurosci. 8 2005 1263 1268
11. S.A. Stanley, J.E. Gagner, S. Damanpour, M. Yoshida, J.S. Dordick, and J.M. Friedman Radio-wave heating of iron oxide nanoparticles can regulate plasma glucose in mice Science 336 2012 604 608
12. K. Nishida, and P.A. Silver Induction of biogenic magnetization and redox control by a component of the target of rapamycin complex 1 signaling pathway PLoS Biol. 10 2012 e1001269
13. T. Kim, D. Moore, and M. Fussenegger Genetically programmed superparamagnetic behavior of mammalian cells J. Biotechnol. 162 2012 237 245
14. E. Toth, L. Helm, and A.E. Merbach Relaxivity of gadolinium (III) complexes: theory and mechanism A.E. Merbach, E. Toth, The Chemistry of Contrast Agents in Medical Magnetic Resonance Imaging 2001 J. Wiley & Sons New York 45 120
15. E.J. Werner, A. Datta, C.J. Jocher, and K.N. Raymond High-relaxivity MRI contrast agents: where coordination chemistry meets medical imaging Angew. Chem. Int. Ed. Engl. 47 2008 8568 8580
16. V. Hsieh, and A. Jasanoff Bioengineered probes for molecular magnetic resonance imaging in the nervous system ACS Chem. Neurosci. 3 2012 593 602
17. P. Caravan The interaction of MS-325 with human serum albumin and its effect on proton relaxation rates J. Am. Chem. Soc. 124 2002 3152 3162
18. U. Schmiedl, M.D. Ogan, M.E. Moseley, and R.C. Brasch Comparison of the contrast-enhancing properties of albumin-(Gd-DTPA) and Gd-DTPA at 2.0 T: and experimental study in rats Am. J. Roentgenol. 147 1986 1263 1270
19. A.A. Gilad, K. Ziv, M.T. McMahon, P.C. van Zijl, M. Neeman, and J.W. Bulte MRI reporter genes J. Nucl. Med. 49 2008 1905 1908
20. G.G. Westmeyer, and A. Jasanoff Genetically controlled MRI contrast mechanisms and their prospects in systems neuroscience research Magn. Reson. Imaging 25 2007 1004 1010
21. G. Vande Velde Quantitative evaluation of MRI-based tracking of ferritin-labeled endogenous neural stem cell progeny in rodent brain Neuroimage 62 2012 367 380
22. B. Iordanova, and E.T. Ahrens In vivo magnetic resonance imaging of ferritin-based reporter visualizes native neuroblast migration Neuroimage 59 2012 1004 1012
23. A.V. Naumova, H. Reinecke, V. Yarnykh, J. Deem, C. Yuan, and C.E. Murry Ferritin overexpression for noninvasive magnetic resonance imaging-based tracking of stem cells transplanted into the heart Mol. Imaging 9 2010 201 210
24. E.M. Brustad, V.S. Lelyveld, C.D. Snow, N. Crook, S.T. Jung, F.M. Martinez, T.J. Scholl, A. Jasanoff, and F.H. Arnold Structure-guided directed evolution of highly selective p450-based magnetic resonance imaging sensors for dopamine and serotonin J. Mol. Biol. 422 2012 245 262
25. M.G. Shapiro, G.G. Westmeyer, P.A. Romero, J.O. Szablowski, B. Küster, A. Shah, C.R. Otey, R. Langer, F.H. Arnold, and A. Jasanoff Directed evolution of a magnetic resonance imaging contrast agent for noninvasive imaging of dopamine Nat. Biotechnol. 28 2010 264 270
26. P. Lauterbur Image formation by induced local interactions: examples employing nuclear magnetic resonance Nature 242 1973 190 191
27. N. Bloembergen, E.M. Purcell, and R.V. Pound Relaxation effects in nuclear magnetic resonance absorption Phys. Rev. 73 1948 679 712
28. F. Bloch, W.W. Hansen, and M. Packard The nuclear induction experiment Phys. Rev. 70 1946 474 485
29. I. Solomon, and N. Bloembergen Nuclear magnetic interactions in the HF molecule J. Chem. Phys. 25 1956 166 261
30. I. Bloembergen Proton relaxation times in paramagnetic solutions J. Chem. Phys. 27 1957 572 573
31. N. Bloembergen, and L.O. Morgan Proton relaxation times in paramagnetic solutions. Effects of electron spin relaxation J. Chem. Phys. 34 1961 842 850
32. J. Kowalewski, D. Kruk, and G. Parigi NMR relaxation in solution of paramagnetic complexes: recent theoretical progress for S ≥ 1 Advances in Inorganic Chemistry 2005 Elsevier 41 104
33. J.H. Freed Dynamic effects of pair correlation functions on spin relaxation by translational diffusion in liquids. II. Finite jumps and independent T1 processes J. Chem. Phys. 68 1978 4034 4037
34. P. Gillis, and S.H. Koenig Transverse relaxation of solvent protons induced by magnetized spheres: application to ferritin, erythrocytes, and magnetite Magn. Reson. Med. 5 1987 323 345
35. A. Roch, R.N. Muller, and P. Gillis Theory of proton relaxation induced by superparamagnetic particles J. Chem. Phys. 110 1999 5403 5411
36. S.H. Koenig, and K.E. Kellar Theory of 1/T1 and 1/T2 NMRD profiles of solutions of magnetic nanoparticles Magn. Reson. Med. 34 1995 227 233
37. P. Caravan, C.T. Farrar, L. Frullano, and R. Uppal Influence of molecular parameters and increasing magnetic field strength on relaxivity of gadolinium- and manganese-based T1 contrast agents Contrast Media Mol. Imaging 4 2009 89 100
38. R.N. Muller, A. Roch, J.-M. Colet, A. Ouakssim, and P. Gillis Particulate Magnetic Contrast Agents The Chemistry of Contrast Agents in Medical Magnetic Resonance Imaging 2001 J. Wiley & Sons New York
39. R.B. Lauffer Paramagnetic metal complexes as water proton relaxation agents for NMR imaging: theory and design Chem. Rev. 87 1987 901 927
40. P. Caravan, J.J. Ellison, T.J. McMurry, and R.B. Lauffer Gadolinium(III) chelates as MRI contrast agents: structure, dynamics, and applications Chem. Rev. 99 1999 2293 2352
41. D.H. Carr, J. Brown, G.M. Bydder, H.J. Weinmann, U. Speck, D.J. Thomas, and I.R. Young Intravenous chelated gadolinium as a contrast agent in NMR imaging of cerebral tumours Lancet 1 1984 484 486
42. P.F. Renshaw, C.S. Owen, A.C. McLaughlin, T.G. Frey, and J.S. Leigh Jr. Ferromagnetic contrast agents: a new approach Magn. Reson. Med. 3 1986 217 225
43. M.H. Mendonca Dias, and P.C. Lauterbur Ferromagnetic particles as contrast agents for magnetic resonance imaging of liver and spleen Magn. Reson. Med. 3 1986 328 330
44. M.B.E. Olsson, B.R.B. Persson, L.G. Salford, and U. Schröder Ferromagnetic particles as contrast agents in T2 NMR imaging Magn. Reson. Imaging 4 1986 437 440
45. Y.W. Jun, J.W. Seo, and J. Cheon Nanoscaling laws of magnetic nanoparticles and their applicabilities in biomedical sciences Acc. Chem. Res. 41 2008 179 189
46. P. Gillis, F. Moiny, and R.A. Brooks On T(2)-shortening by strongly magnetized spheres: a partial refocusing model Magn. Reson. Med. 47 2002 257 263
47. L. Josephson, J.M. Perez, and R. Weissleder Magnetic nanosensors for the detection of oligonucleotide sequences Angew. Chem. Int. Ed. 40 2001 3204 3206
48. J.M. Perez, L. Josephson, T. O'Loughlin, D. Hogemann, and R. Weissleder Magnetic relaxation switches capable of sensing molecular interactions Nat. Biotechnol. 20 2002 816 820
49. Y. Matsumoto, and A. Jasanoff T2 relaxation induced by clusters of superparamagnetic nanoparticles: Monte Carlo simulations Magn. Reson. Imaging 26 2008 994 998
50. D.D. Schwert, J.A. Davies, and N. Richardson Non-Gadolinium-Based MRI Contrast Agents Contrast Agents I 2002 Springer Berlin Heidelberg Berlin, Heidelberg 165 199
51. C.l.S. Bonnet, P.H. Fries, S. Crouzy, and P. Delangle Outer-sphere investigation of MRI relaxation contrast agents. Example of a cyclodecapeptide gadolinium complex with second-sphere water J. Phys. Chem. B 114 2010 8770 8781
52. E. Toth, L. Helm, and A.E. Merbach Relaxivity of MRI Contrast Agents Contrast Agents I 2002 Springer Berlin Heidelberg Berlin, Heidelberg 61 101
53. A. Einstein Über die von der molekularkinetischen theorie der wärme geforderte bewegung von in ruhenden flüssigkeiten suspendierten teilchen Ann. Phys. 17 1905 549 560
54. G. Diakova, Y. Goddard, J.P. Korb, and R.G. Bryant Water-proton-spin- lattice-relaxation dispersion of paramagnetic protein solutions J. Magn. Reson. 208 2011 195 203
55. R.L. Rebodos, and P.J. Vikesland Effects of oxidation on the magnetization of nanoparticulate magnetite Langmuir 26 2010 16745 16753
56. M.E.Y. Mohie-Eldin, R.B. Frankel, and L. Gunther A comparison of the magnetic properties of polysaccharide iron complex (PIC) and ferritin J. Magn. Magn. Mater. 135 1994 65 81
57. Y. Gossuin, A. Roch, R.N. Muller, and P. Gillis Relaxation induced by ferritin and ferritin-like magnetic particles: the role of proton exchange Magn. Reson. Med. 43 2000 237 243
58. J. Vymazal, O. Zak, J.W. Bulte, P. Aisen, and R.A. Brooks T1 and T2 of ferritin solutions: effect of loading factor Magn. Reson. Med. 36 1996 61 65
59. L. Pauling, and C.D. Coryell The magnetic properties and structure of hemoglobin, oxyhemoglobin and carbonmonoxyhemoglobin Proc. Natl. Acad. Sci. USA 22 1936 210 216
60. S. Ogawa, T.M. Lee, A.R. Kay, and D.W. Tank Brain magnetic resonance imaging with contrast dependent on blood oxygenation Proc. Natl. Acad. Sci. USA 87 1990 9868 9872
61. J.L. Boxerman, P.A. Bandettini, K.K. Kwong, J.R. Baker, T.L. Davis, B.R. Rosen, and R.M. Weisskoff The intravascular contribution to fMRI signal change: Monte Carlo modeling and diffusion-weighted studies in vivo Magn. Reson. Med. 34 1995 4 10
62. C.T. Kapff, and J.H. Jandl Blood, Atlas and Sourcebook of Hematology 1991 Little, Brown Boston
63. P.A. Bandettini, E.C. Wong, R.S. Hinks, R.S. Tikofsky, and J.S. Hyde Time course EPI of human brain function during task activation Magn. Reson. Med. 25 1992 390 397
64. S. Ogawa, D.W. Tank, R. Menon, J.M. Ellermann, S.G. Kim, H. Merkle, and K. Ugurbil Intrinsic signal changes accompanying sensory stimulation: functional brain mapping with magnetic resonance imaging Proc. Natl. Acad. Sci. USA 89 1992 5951 5955
65. K.K. Kwong Dynamic magnetic resonance imaging of human brain activity during primary sensory stimulation Proc. Natl. Acad. Sci. USA 89 1992 5675 5679
66. P.V. Prasad, and A. Priatna Functional imaging of the kidneys with fast MRI techniques Eur. J. Radiol. 29 1999 133 148
67. P.G. Carlier Skeletal muscle perfusion and oxygenation assessed by dynamic NMR imaging and spectroscopy Adv. Exp. Med. Biol. 701 2011 341 346
68. T.K. Tran, N. Sailasuta, R. Hurd, and T. Jue Spatial distribution of deoxymyoglobin in human muscle: an index of local tissue oxygenation NMR Biomed. 12 1999 26 30
69. R.D. Shonat, and A.P. Koretsky Expression of myoglobin in the transgenic mouse brain Adv. Exp. Med. Biol. 530 2003 331 345
70. F.A. Fischbach, P.M. Harrison, and T.G. Hoy The structural relationship between ferritin protein and its mineral core J. Mol. Biol. 39 1969 235 238
71. P.M. Harrison, F.A. Fischbach, T.G. Hoy, and G.H. Haggis Ferric oxyhydroxide core of ferritin Nature 216 1967 1188 1190
72. B. Cohen, H. Dafni, G. Meir, A. Harmelin, and M. Neeman Ferritin as an endogenous MRI reporter for noninvasive imaging of gene expression in C6 glioma tumors Neoplasia (N.Y.) 7 2005 109 117
73. G. Genove, U. DeMarco, H. Xu, W.F. Goins, and E.T. Ahrens A new transgene reporter for in vivo magnetic resonance imaging Nat. Med. 11 2005 450 454
74. B. Cohen, K. Ziv, V. Plaks, T. Israely, V. Kalchenko, A. Harmelin, L.E. Benjamin, and M. Neeman MRI detection of transcriptional regulation of gene expression in transgenic mice Nat. Med. 13 2007 498 503
75. J. Kaplan, I. Jordan, and A. Sturrock Regulation of the transferrin-independent iron transport system in cultured cells J. Biol. Chem. 266 1991 2997 3004
76. M. Karin, and B. Mintz Receptor-mediated endocytosis of transferrin in developmentally totipotent mouse teratocarcinoma stem cells J. Biol. Chem. 256 1981 3245 3252
77. R.J. Rothman, A. Serroni, and J.L. Farber Cellular pool of transient ferric iron, chelatable by deferoxamine and distinct from ferritin, that is involved in oxidative cell injury Mol. Pharmacol. 42 1992 703 710
78. A.E. Deans, Y.Z. Wadghiri, L.M. Bernas, X. Yu, B.K. Rutt, and D.H. Turnbull Cellular MRI contrast via coexpression of transferrin receptor and ferritin Magn. Reson. Med. 56 2006 51 59
79. O. Zurkiya, A.W.S. Chan, and X. Hu MagA is sufficient for producing magnetic nanoparticles in mammalian cells, making it an MRI reporter Magn. Reson. Med. 59 2008 1225 1231
80. B.B. Bartelle, K.U. Szulc, G.A. Suero-Abreu, J.J. Rodriguez, and D.H. Turnbull Divalent metal transporter, DMT1: a novel MRI reporter protein Magn. Reson. Med. 2012 [Epub ahead of print]
81. R.B. Lauffer, and T.J. Brady Preparation and water relaxation properties of proteins labeled with paramagnetic metal chelates Magn. Reson. Imaging 3 1985 11 16
82. E.C. Unger, W.G. Totty, D.M. Neufeld, F.L. Otsuka, W.A. Murphy, M.S. Welch, J.M. Connett, and G.W. Philpott Magnetic resonance imaging using gadolinium labeled monoclonal antibody Invest. Radiol. 20 1985 693 700
83. P. Shreve, and A.M. Aisen Monoclonal antibodies labeled with polymeric paramagnetic ion chelates Magn. Reson. Med. 3 1986 336 340
84. C.W.H. Wu Development of a MR-visible compound for tracing neuroanatomical connections in vivo Neuron 70 2011 229 243
85. R. Weissleder, A. Moore, U. Mahmood, R. Bhorade, H. Benveniste, E.A. Chiocca, and J.P. Basilion In vivo magnetic resonance imaging of transgene expression Nat. Med. 6 2000 351 355
86. M. Zhao, D.A. Beauregard, L. Loizou, B. Davletov, and K.M. Brindle Non-invasive detection of apoptosis using magnetic resonance imaging and a targeted contrast agent Nat. Med. 7 2001 1241 1244
87. S.G. Ruehm, C. Corot, P. Vogt, S. Kolb, and J.F. Debatin Magnetic resonance imaging of atherosclerotic plaque with ultrasmall superparamagnetic particles of iron oxide in hyperlipidemic rabbits Circulation 103 2001 415 422
88. S. Cerdan, H.R. Lotscher, B. Kunnecke, and J. Seelig Monoclonal antibody-coated magnetite particles as contrast agents in magnetic resonance imaging of tumors Magn. Reson. Med. 12 1989 151 163
89. L.X. Tiefenauer, G. Kuhne, and R.Y. Andres Antibody-magnetite nanoparticles: in vitro characterization of a potential tumor-specific contrast agent for magnetic resonance imaging Bioconjug. Chem. 4 1993 347 352
90. E.Y. Sun, R. Weissleder, and L. Josephson Continuous analyte sensing with magnetic nanoswitches Small 2 2006 1144 1147
91. T. Atanasijevic, M. Shusteff, P. Fam, and A. Jasanoff Calcium-sensitive MRI contrast agents based on superparamagnetic iron oxide nanoparticles and calmodulin Proc. Natl. Acad. Sci. USA 103 2006 14707 14712
92. T.M.S. Chang Blood Substitutes: Principles, Methods, Products, and Clinical Trials 1997 Karger Landes Systems Basel, New York
93. P.Z. Sun, Z.B. Schoening, and A. Jasanoff In vivo oxygen detection using exogenous hemoglobin as a contrast agent in magnetic resonance microscopy Magn. Reson. Med. 49 2003 609 614
94. J.D. Bloom, and F.H. Arnold In the light of directed evolution: pathways of adaptive protein evolution Proc. Natl. Acad. Sci. USA 106 Suppl. 1 2009 9995 10000
95. J. Vymazal, M. Hajek, N. Patronas, J.N. Giedd, J.W. Bulte, C. Baumgarner, V. Tran, and R.A. Brooks The quantitative relation between T1-weighted and T2-weighted MRI of normal gray matter and iron concentration J. MRI 5 1995 554 560
96. V. Mani, K.C. Briley-Saebo, F. Hyafil, and Z.A. Fayad Feasibility of in vivo identification of endogenous ferritin with positive contrast MRI in rabbit carotid crush injury using GRASP Magn. Reson. Med. 56 2006 1096 1106
97. B. Yao, T.Q. Li, P. Gelderen, K. Shmueli, J.A. de Zwart, and J.H. Duyn Susceptibility contrast in high field MRI of human brain as a function of tissue iron content Neuroimage 44 2009 1259 1266
98. M. Uchida Targeting of cancer cells with ferrimagnetic ferritin cage nanoparticles J. Am. Chem. Soc. 128 2006 16626 16633
99. M.G. Shapiro, J.O. Szablowski, R. Langer, and A. Jasanoff Protein nanoparticles engineered to sense kinase activity in MRI J. Am. Chem. Soc. 131 2009 2484 2486
100. A.J. Shaywitz, S.L. Dove, J.M. Kornhauser, A. Hochschild, and M.E. Greenberg Magnitude of the CREB-dependent transcriptional response is determined by the strength of the interaction between the kinase-inducible domain of CREB and the KIX domain of CREB-binding protein Mol. Cell. Biol. 20 2000 9409 9422
101. K.M. Bennett, E.M. Shapiro, C.H. Sotak, and A.P. Koretsky Controlled aggregation of ferritin to modulate MRI relaxivity Biophys. J. 95 2008 342 351
102. B. Iordanova, C.S. Robison, and E.T. Ahrens Design and characterization of a chimeric ferritin with enhanced iron loading and transverse NMR relaxation rate J. Biol. Inorg. Chem. 15 2010 957 965
103. V.S. Lelyveld, E. Brustad, F.H. Arnold, and A. Jasanoff Metal-substituted protein MRI contrast agents engineered for enhanced relaxivity and ligand sensitivity J. Am. Chem. Soc. 133 2011 649 651
104. F.C. Meldrum, B.R. Heywood, and S. Mann Magnetoferritin: in vitro synthesis of a novel magnetic protein Science 257 1992 522 523
105. J.W. Bulte Magnetoferritin: characterization of a novel superparamagnetic MR contrast agent J. MRI 4 1994 497 505
106. V.C. Jordan, M.R. Caplan, and K.M. Bennett Simplified synthesis and relaxometry of magnetoferritin for magnetic resonance imaging Magn. Reson. Med. 64 2010 1260 1266
107. P. Sánchez, E. Valero, N. Gálvez, J.M. Domínguez- Vera, M. Marinone, G. Poletti, M. Corti, and A. Lascialfari MRI relaxation properties of water-soluble apoferritin-encapsulated gadolinium oxide-hydroxide nanoparticles Dalton Trans. 2009 800 804
108. F.K. Kálmán, S. Geninatti-Crich, and S. Aime Reduction/dissolution of a beta-MnOOH nanophase in the ferritin cavity to yield a highly sensitive, biologically compatible magnetic resonance imaging agent Angew. Chem. Int. Ed. Engl. 49 2010 612 615
109. M. Allen, J.W.M. Bulte, L. Liepold, G. Basu, H.A. Zywicke, J.A. Frank, M. Young, and T. Douglas Paramagnetic viral nanoparticles as potential high-relaxivity magnetic resonance contrast agents Magn. Reson. Med. 54 2005 807 812
110. L. Liepold, S. Anderson, D. Willits, L. Oltrogge, J.A. Frank, T. Douglas, and M. Young Viral capsids as MRI contrast agents Magn. Reson. Med. 58 2007 871 879
111. S. Qazi, L.O. Liepold, M.J. Abedin, B. Johnson, P. Prevelige, J.A. Frank, and T. Douglas P22 viral capsids as nanocomposite high-relaxivity MRI contrast agents Mol. Pharm. 2012 [Epub ahead of print]
112. S. Aime, L. Frullano, and S. Geninatti Crich Compartmentalization of a gadolinium complex in the apoferritin cavity: a route to obtain high relaxivity contrast agents for magnetic resonance imaging Angew. Chem. Int. Ed. Engl. 41 2002 1017 1019
113. B. Sana, C.L. Poh, and S. Lim A manganese-ferritin nanocomposite as an ultrasensitive T2 contrast agent Chem. Commun. (Cambridge, U.K.) 48 2012 862 864
114. L.S. Karfeld, S.R. Bull, N.E. Davis, T.J. Meade, and A.E. Barron Use of a genetically engineered protein for the design of a multivalent MRI contrast agent Bioconjug. Chem. 18 2007 1697 1700
115. L.S. Karfeld-Sulzer, E.A. Waters, N.E. Davis, T.J. Meade, and A.E. Barron Multivalent protein polymer MRI contrast agents: controlling relaxivity via modulation of amino acid sequence Biomacromolecules 11 2010 1429 1436
116. J.J. Yang Rational design of protein-based MRI contrast agents J. Am. Chem. Soc. 130 2008 9260 9267
117. Z. Grabarek Structural basis for diversity of the EF-hand calcium-binding proteins J. Mol. Biol. 359 2006 509 525
118. J.L. Gifford, M.P. Walsh, and H.J. Vogel Structures and metal-ion-binding properties of the Ca2+-binding helix-loop-helix EF-hand motifs Biochem. J. 405 2007 199 221
119. P. Caravan, J.M. Greenwood, J.T. Welch, and S.J. Franklin Gadolinium-binding helix-turn-helix peptides: DNA-dependent MRI contrast agents Chem. Commun. (Cambridge, U.K.) 2003 2574 2575
120. T. Atanasijevic, X.A. Zhang, S.J. Lippard, and A. Jasanoff MRI sensing based on the displacement of paramagnetic ions from chelated complexes Inorg. Chem. 49 2010 2589 2591
121. K.J. Franz, M. Nitz, and B. Imperiali Lanthanide-binding tags as versatile protein coexpression probes ChemBioChem 4 2003 265 271
122. M. Nitz, K.J. Franz, R.L. Maglathlin, and B. Imperiali A powerful combinatorial screen to identify high-affinity terbium(III)-binding peptides ChemBioChem 4 2003 272 276
123. K.D. Daughtry, L.J. Martin, A. Sarraju, B. Imperiali, and K.N. Allen Tailoring encodable lanthanide-binding tags as MRI contrast agents ChemBioChem 13 2012 2567 2574
124. A.A. Gilad Artificial reporter gene providing MRI contrast based on proton exchange Nat. Biotechnol. 25 2007 217 219
125. P.D. Hempstead, S.J. Yewdall, A.R. Fernie, D.M. Lawson, P.J. Artymiuk, D.W. Rice, G.C. Ford, and P.M. Harrison Comparison of the three-dimensional structures of recombinant human H and horse L ferritins at high resolution J. Mol. Biol. 268 1997 424 448
126. H. Li, and T.L. Poulos The structure of the cytochrome p450BM-3 haem domain complexed with the fatty acid substrate, palmitoleic acid Nat. Struct. Biol. 4 1997 140 146
127. 2O, and its relevance to NMR studies of the conformational behavior of the lanthanide complexes formed by the macrocyclic ligand DOTA Inorg. Chem. 23 1984 359 363